INmune Bio(INMB) - 2022 Q4 - Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants David Moss - CFO RJ Tesi - CEO CJ Barnum - Head of Neuroscience Mark Lowdell - Chief Scientific Officer Conference Call Participants Jason McCarthy - Maxim Group Tom Shrader - BTIG Daniel Carlson - Tailwinds Research Operator Greetings, and welcome to the INmune Bio Fourth Quarter and Full Year 2022 Earnings Call. This conference will be recorded. A brief question-and-answer session will follow the ...